Marta Cardoso
Overview
Explore the profile of Marta Cardoso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peixoto A, Ferreira D, Miranda A, Relvas-Santos M, Freitas R, Veth T, et al.
iScience
. 2025 Feb;
28(2):111758.
PMID: 39906564
Bladder tumors with aggressive characteristics often present microenvironmental niches marked by low oxygen levels (hypoxia) and limited glucose supply due to inadequate vascularization. The molecular mechanisms facilitating cellular adaptation to...
2.
Silva M, Ferreira L, Bras N, Torres L, Brandao A, Pinheiro M, et al.
J Biomed Sci
. 2024 Jul;
31(1):74.
PMID: 39014450
Background: Prostate cancer (PrCa) is the most frequently diagnosed cancer in men. Variants in known moderate- to high-penetrance genes explain less than 5% of the cases arising at early-onset (< ...
3.
Paulo P, Cardoso M, Brandao A, Pinto P, Falconi A, Pinheiro M, et al.
Genes Chromosomes Cancer
. 2023 Jul;
62(12):710-720.
PMID: 37436117
Prostate cancer (PrCa) is one of the three most frequent and deadliest cancers worldwide. The discovery of PARP inhibitors for the treatment of tumors with deleterious variants in homologous recombination...
4.
Cardoso M, Maia S, Brandao A, Sahasrabudhe R, Lott P, Belter N, et al.
Br J Cancer
. 2022 Dec;
128(6):1077-1085.
PMID: 36564567
Background: Prostate cancer (PrCa) is one of the most hereditable human cancers, however, only a small fraction of patients has been shown to carry deleterious variants in known cancer predisposition...
5.
Oliveira R, Cardoso M, Rocha A
Opt Express
. 2022 Feb;
30(2):2230-2246.
PMID: 35209368
In this work we demonstrate the fabrication and characterization of a temperature insensitive, two-dimensional curvature sensor using a resin based Fabry-Pérot interferometer, constructed using a multicore fiber (MCF). The fabrication...
6.
Karlsson Q, Brook M, Dadaev T, Wakerell S, Saunders E, Muir K, et al.
Eur Urol Oncol
. 2021 Jan;
4(4):570-579.
PMID: 33436325
Background: Germline ATM mutations are suggested to contribute to predisposition to prostate cancer (PrCa). Previous studies have had inadequate power to estimate variant effect sizes. Objective: To precisely estimate the...
7.
Brandao A, Paulo P, Maia S, Pinheiro M, Peixoto A, Cardoso M, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33158149
The identification of recurrent founder variants in cancer predisposing genes may have important implications for implementing cost-effective targeted genetic screening strategies. In this study, we evaluated the prevalence and relative...
8.
Page E, Bancroft E, Brook M, Assel M, Hassan Al Battat M, Thomas S, et al.
Eur Urol
. 2019 Sep;
76(6):831-842.
PMID: 31537406
Background: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2...
9.
Schumacher F, Olama A, Berndt S, Benlloch S, Ahmed M, Saunders E, et al.
Nat Genet
. 2019 Jan;
51(2):363.
PMID: 30622367
In the version of this article initially published, the name of author Manuela Gago-Dominguez was misspelled as Manuela Gago Dominguez. The error has been corrected in the HTML and PDF...
10.
Dadaev T, Saunders E, Newcombe P, Anokian E, Leongamornlert D, Brook M, et al.
Nat Commun
. 2018 Jun;
9(1):2256.
PMID: 29892050
Prostate cancer is a polygenic disease with a large heritable component. A number of common, low-penetrance prostate cancer risk loci have been identified through GWAS. Here we apply the Bayesian...